IPP Bureau
Govt celebrates 7th Ayurveda Day 2022
By IPP Bureau - October 23, 2022
A MoU was signed between Ministry of Ayush and Ministry of Tribal Affairs to collaborate in Ayush sector
Merck’s PREVYMIS effective for prevention of cytomegalovirus disease in adults post kidney transplantation
By IPP Bureau - October 23, 2022
Separate Phase 3 study evaluating 200 days of therapy with PREVYMIS in HSCT recipients at high risk of late clinically significant CMV infection recently completed, meeting its primary endpoint
IHL Launches Heart Health Calculator
By IPP Bureau - October 23, 2022
Tech-driven calculator, which serves as a preventive tool that helps in heart risk assessment using several factors
Aragen to operationalize Hyderabad formulation manufacturing facility by Jan 2023
By IPP Bureau - October 21, 2022
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
Glenmark launches Zita D for adults with Type 2 diabetes having comorbidities
By IPP Bureau - October 21, 2022
A well researched and affordable fixed dose combination, which will significantly improve the glycemic control in adult patients suffering from uncontrolled Type 2 diabetes, especially the ones with comorbidities
Aster Hospital opens 100-bed multi-specialty facility in Sharjah
By IPP Bureau - October 21, 2022
The newest facility has all the core specialties like Obstetrics and Gynaecology, Orthopaedics, Neurology, Cardiology, Paediatrics, General Surgery, and Urology
Lupin launches Paliperidone Extended-Release Tablets in US
By IPP Bureau - October 21, 2022
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of US $112 million in the US
Aarti Drugs Q2 FY23 revenue up 19%; Profit down 5.6%
By IPP Bureau - October 21, 2022
Around 62% of the revenues came from the domestic market and 38% from the exports market for Q2 FY23 for a standalone business
Cadila Pharma's Esiloc wins "Best Launch of the Year"
By IPP Bureau - October 21, 2022
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
Lupin to acquire two inhalation brands from Sunovion for US$75 million
By IPP Bureau - October 20, 2022
The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.
Parexel bags Global Customer Value Leadership Award
By IPP Bureau - October 20, 2022
The award recognizes Parexel for delivering the best decentralized trial experience for customers through its capabilities, expertise, and patient recruitment and retention strategies
Health Minister Mandaviya inaugurates CGHS Wellness Centres
By IPP Bureau - October 20, 2022
CGHS would give robust coverage to pensioners and with new innovations and practices
MedScapeIndia launches a poster of 'Girl Child Anthem'
By IPP Bureau - October 20, 2022
The girl child anthem will portray a celebration of a girl child.
Syngene Q2 FY23 PAT up 11% to Rs. 102 Cr
By IPP Bureau - October 20, 2022
Revenue from operations up 26% to Rs. 768 crores
USFDA visit to Alembic Pharmaceuticals Panelav facility
By IPP Bureau - October 19, 2022
None of the observations are related to data integrity and Alembic Pharmaceuticals management believes that they are addressable
